899 related articles for article (PubMed ID: 18489988)
1. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
2. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment.
Chang C; Niu D; Zhou H; Zhang Y; Li F; Gong F
Cytotherapy; 2008; 10(8):796-805. PubMed ID: 18979304
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
Zhou H; Tian HM; Long Y; Zhang XX; Zhong L; Deng L; Chen XH; Li XQ
Chin Med J (Engl); 2009 Nov; 122(21):2573-9. PubMed ID: 19951572
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
Lin P; Chen L; Yang N; Sun Y; Xu YX
Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
[TBL] [Abstract][Full Text] [Related]
8. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
[TBL] [Abstract][Full Text] [Related]
9. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.
Lee RH; Seo MJ; Reger RL; Spees JL; Pulin AA; Olson SD; Prockop DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17438-43. PubMed ID: 17088535
[TBL] [Abstract][Full Text] [Related]
10. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo.
Davani B; Ikonomou L; Raaka BM; Geras-Raaka E; Morton RA; Marcus-Samuels B; Gershengorn MC
Stem Cells; 2007 Dec; 25(12):3215-22. PubMed ID: 17901402
[TBL] [Abstract][Full Text] [Related]
11. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
Chou SH; Kuo TK; Liu M; Lee OK
J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
[TBL] [Abstract][Full Text] [Related]
12. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
[TBL] [Abstract][Full Text] [Related]
13. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
14. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
[TBL] [Abstract][Full Text] [Related]
15. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats.
Abdel Aziz MT; El-Asmar MF; Haidara M; Atta HM; Roshdy NK; Rashed LA; Sabry D; Youssef MA; Abdel Aziz AT; Moustafa M
Med Sci Monit; 2008 Nov; 14(11):BR249-55. PubMed ID: 18971868
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.
Figliuzzi M; Cornolti R; Perico N; Rota C; Morigi M; Remuzzi G; Remuzzi A; Benigni A
Transplant Proc; 2009 Jun; 41(5):1797-800. PubMed ID: 19545731
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.
Kunter U; Rong S; Boor P; Eitner F; Müller-Newen G; Djuric Z; van Roeyen CR; Konieczny A; Ostendorf T; Villa L; Milovanceva-Popovska M; Kerjaschki D; Floege J
J Am Soc Nephrol; 2007 Jun; 18(6):1754-64. PubMed ID: 17460140
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
Zhang ZL; Tong J; Lu RN; Scutt AM; Goltzman D; Miao DS
Bone Marrow Transplant; 2009 Jan; 43(1):69-81. PubMed ID: 18711348
[TBL] [Abstract][Full Text] [Related]
20. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]